Qing XIe
2 clinical trials · 2 recruiting · OTHER
Trials by Qing XIe
RECRUITINGNCT05671315
A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients
China's new cases and deaths of hepatocellular carcinoma (HCC) rank first in the world. hepatocellular carcinoma is the third most morbid, second-most mortal malignancy in China....
Sponsor: Qing XIeEnrolling: 2679 locations
Chronic Hepatitis BIntermediate to High Risk of HCC
RECRUITINGNCT06323681
Pegylated Interferon α in Previously Interferon-treated CHB(Leading Study)
Previous clinical practice and exploratory studies suggest that some patients who have not achieved functional cure in the first round of interferon therapy can achieve HBsAg...
Sponsor: Qing XIeEnrolling: 20161 location
Chronic Hepatitis b